For the year ending 2025-12-31, ABX had -$93,831,950 decrease in cash & cash equivalents over the period. -$26,611,908 in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | 37,311,952 |
| Depreciation and amortization | 18,605,114 |
| Allowance for credit losses | 1,245,575 |
| Impairment of other investment | 500,000 |
| Stock-based compensation | 15,519,382 |
| Amortization of debt issuance costs | 2,405,939 |
| Unrealized loss on equity securities, at fair value | 0 |
| Unrealized gain on other investments | 204,016 |
| Non-cash gain on policy trades | 0 |
| Unrealized gain on policies, at fair value | 49,287,046 |
| Loss (gain) on change in fair value of debt | 3,362,103 |
| Loss on change in fair value of warrant liability | 1,704,193 |
| Non-cash interest income | 384,618 |
| Deferred income taxes | 824,674 |
| Non-cash interest expense-Related Party | 1,588,564 |
| Non-cash interest expense-Nonrelated Party | 143,629 |
| Non-cash lease expense | -422,954 |
| Non-cash other income | 1,750,000 |
| Accounts receivable | 798,821 |
| Accounts receivable, related party | 5,607,465 |
| Equity securities, at fair value | 0 |
| Management and performance fee receivable, related party-Related Party | -1,420,839 |
| Prepaid expenses and other current assets | 948,416 |
| Other assets | -115,807 |
| Accrued expenses | 3,948,939 |
| Accrued transaction costs | 1,852,971 |
| Contract liabilities, deposits on pending settlement | -2,304,359 |
| Other current liabilities | -4,303,850 |
| Income tax payable | 3,022,552 |
| Income tax receivable | -1,688,618 |
| Retrocession fees payable | -44,709 |
| Net change in life settlement policies, at fair value | 49,172,436 |
| Net change in life settlement policies, at cost | -165,672 |
| Net cash used in operating activities | -25,680,465 |
| Origination of note receivable | 7,000,000 |
| Acquisition of businesses, net of cash acquired | 1,647,725 |
| Purchase of property and equipment | 931,443 |
| Purchase of intangible assets | 0 |
| Purchase of other investments | 11,699,569 |
| Purchase of available for sale securities | 2,000,000 |
| Change in due from affiliates | 0 |
| Net cash used in investing activities | -23,278,737 |
| Issuance of long term debt | 50,000,000 |
| Issuance of long term-debt, at fair value | 26,048,884 |
| Payment of discounts and financing costs | 1,475,195 |
| Repayment of debt-Nonrelated Party | 1,125,000 |
| Repayment of debt, at fair value | 51,226,628 |
| Repayment of debt-Related Party | 0 |
| Common stock issuance | 0 |
| Common stock issuance transaction costs | 3,473,280 |
| Repurchase of common stock | 43,783,458 |
| Transaction costs | 0 |
| Payment of series a convertible preferred dividend | 287,500 |
| Payment of common dividend | 19,550,571 |
| Due to affiliates-Related Party | 0 |
| Warrant conversions | 0 |
| Due to affiliates-Affiliated Entity | 0 |
| Net cash (used in) provided by financing activities | -44,872,748 |
| Net (decrease) increase in cash and cash equivalents | -93,831,950 |
| Cash and cash equivalents at the beginning of the period | 131,944,282 |
| Cash and cash equivalents at the end of the period | 38,112,332 |
Abacus Global Management, Inc. (ABX)
Abacus Global Management, Inc. (ABX)